Pro-Dex Gross Profit 2010-2024 | PDEX

Pro-Dex gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Pro-Dex Annual Gross Profit
(Millions of US $)
2023 $13
2022 $13
2021 $14
2020 $13
2019 $10
2018 $8
2017 $7
2016 $5
2015 $4
2014 $3
2013 $4
2012 $5
2011 $10
2010 $8
2009 $7
Pro-Dex Quarterly Gross Profit
(Millions of US $)
2024-03-31 $4
2023-12-31 $3
2023-09-30 $4
2023-06-30 $3
2023-03-31 $4
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $3
2021-12-31 $3
2021-09-30 $3
2021-06-30 $3
2021-03-31 $4
2020-12-31 $3
2020-09-30 $3
2020-06-30 $4
2020-03-31 $3
2019-12-31 $3
2019-09-30 $3
2019-06-30 $3
2019-03-31 $2
2018-12-31 $2
2018-09-30 $3
2018-06-30 $2
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $2
2017-03-31 $2
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $2
2011-06-30 $3
2011-03-31 $3
2010-12-31 $2
2010-09-30 $2
2010-06-30 $2
2010-03-31 $2
2009-12-31 $2
2009-09-30 $2
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.065B $0.046B
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Biolase (BIOL) United States $0.004B 0.00